Orphalan
Frank Verheggen is an accomplished professional with extensive experience in clinical operations and development within the pharmaceutical industry. Currently serving as Head of Clinical Operations at Orphalan and gmp-orphan SA since January 2021 and October 2019 respectively, Frank has held multiple leadership roles including Director of Clinical Operations and consulting positions. Previous experience includes roles at CDOC, Venn Life Sciences, Theramex, and Astellas Pharma Europe, where Frank directed clinical program management across various therapeutic areas such as pediatrics, cardiology, and oncology. Frank holds a Master of Science in Biochemistry and Molecular Biology from Wageningen University & Research and has pursued advanced training in Business Management and Pharma Business Development.
This person is not in any offices
Orphalan
Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference.